A continuous growth in these early indicators have been reported. However, the increase is not seen reflected on hospitalizations and deaths.
The sending of information was agreed at a meeting on May 25 between the institute and Anvisa, which will now proceed with the evaluation of the request.
Severe acute respiratory syndrome may be caused by SARS-CoV-2 and has been monitored as a parameter to track the COVID-19 pandemic in Brazil since 2020.
The move was based on the improved epidemiological landscape and the progress of the vaccination campaign. Despite the measure, no public health policy will be interrupted.
The expenses incurred in transportation will be borne by the recipient country, or by budget allocations from the Brazilian government or other collaborators.
Português 
Español 
